Financials

News Discussions Technicals Seasonals

GENIL fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

Gen Ilaç ve Saglik Ürünleri Sanayi ve Ticaret AS operates as a supplier of orphan drugs. It offers drugs against endocrinology, neurology, onco-haematology , nephrology, and metabolism disorders. Its products include Cajex, Contra-K, Epamor, Ferint, Genium, Genkort, Intrafen, Ilopera, Novils, Parigen, Pleksor, and Vorigen. The company was founded in 1998 and is headquartered in Ankara, Turkey.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

GENIL does not pay dividends

The company has not previously paid dividends and at the moment there is no information about whether it is going to pay them in the future

Financial health

Financial position and solvency of the company